Intended for healthcare professionals

CCBYNC Open access
Research

Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4772 (Published 29 August 2019) Cite this as: BMJ 2019;366:l4772